ARTICLE | Clinical News
Orencia abatacept: Phase III data
December 6, 2010 8:00 AM UTC
The double-blind, placebo-controlled, international Phase III ACQUIRE trial in 1,457 patients with moderate to severe RA and an inadequate response to methotrexate showed that weekly subcutaneous inje...